These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


345 related items for PubMed ID: 6341476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
    Rhodes AR, Mihm MC, Weinstock MA.
    Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Intraepidermal distribution patterns of melanocytes in the melanocytic lesions on the sole: proposed criteria for histopathologic diagnosis of plantar malignant melanoma in situ].
    Saida T, Yoshida N.
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):553-60. PubMed ID: 2585770
    [Abstract] [Full Text] [Related]

  • 8. [Dysplastic melanocytic nevi: quantitative ultrastructural investigation comparing intraepidermal melanocytes of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and normal skin].
    Seki Y, Fitzpatrick TB, Rhodes AR.
    Nihon Hifuka Gakkai Zasshi; 1988 Oct; 98(11):1093-103. PubMed ID: 3225938
    [No Abstract] [Full Text] [Related]

  • 9. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
    Sagebiel RW.
    J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fine structural characterization of melanosomes in dysplastic nevi.
    Takahashi H, Horikoshi T, Jimbow K.
    Cancer; 1985 Jul 01; 56(1):111-23. PubMed ID: 4005780
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.
    Aronson PJ, Ito K, Fukaya T, Hashimoto K, Mehregan AH.
    J Invest Dermatol; 1988 Apr 01; 90(4):452-8. PubMed ID: 3280697
    [Abstract] [Full Text] [Related]

  • 13. The epidermal melanin unit in the pathophysiology of malignant melanoma.
    Jimbow K, Salopek TG, Dixon WT, Searles GE, Yamada K.
    Am J Dermatopathol; 1991 Apr 01; 13(2):179-88. PubMed ID: 2029092
    [Abstract] [Full Text] [Related]

  • 14. Correlation of clinical and histopathologic features in clinically atypical melanocytic nevi.
    Barnhill RL, Roush GC.
    Cancer; 1991 Jun 15; 67(12):3157-64. PubMed ID: 2044059
    [Abstract] [Full Text] [Related]

  • 15. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC, Dubin N, Barnhill RL.
    J Am Acad Dermatol; 1993 Oct 15; 29(4):555-62. PubMed ID: 8408790
    [Abstract] [Full Text] [Related]

  • 16. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC, Barnhill RL.
    Br J Cancer; 1991 Nov 15; 64(5):943-7. PubMed ID: 1931621
    [Abstract] [Full Text] [Related]

  • 17. Nonpigmented dysplastic melanocytic nevi.
    Knoell KA, Hendrix JD, Patterson JW, McHargue CA, Wilson BB, Greer KE.
    Arch Dermatol; 1997 Aug 15; 133(8):992-4. PubMed ID: 9267246
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The histological spectrum of acquired nevi. An analysis of the intraepidermal melanocytic proliferation in common and dysplastic nevi.
    Urso C, Bondi R.
    Pathol Res Pract; 1994 Jun 15; 190(6):609-14. PubMed ID: 7984520
    [Abstract] [Full Text] [Related]

  • 20. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
    Maeda K, Maeda K, Jimbow K.
    J Invest Dermatol; 1988 Sep 15; 91(3):247-50. PubMed ID: 3411143
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.